The effect of paramagnetic contrast in choline peak in patients with glioblastoma multiforme might not be significant

American Journal of Neuroradiology

Volumn 34, Issue 1, 2013, Pages 80-84

  Lima, E C ^a   Otaduy, M C G ^a   Tsunemi, M ^a   Pincerato, R ^a   Cardoso, E F ^a   Rosemberg, S ^a   Aguiar, P H ^a   Cerri, G G ^a   Leite, C C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; GADOLINIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HEMISPHERE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN NEOPLASMS; CHOLINE; CONTRAST MEDIA; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; GADOLINIUM; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84873621221     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3181     Document Type: Article

References (19)

1. Howe FA, Opstad KS. 1HMR spectroscopy of brain tumours and masses. NMR Biomed 2003;16:123-31
2. Law M. MR spectroscopy of brain tumors. Top Magn Reson Imaging 2004;15:291-313
3. Leclerc X, Huisman TA, Sorensen AG. The potential of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis and management of patients with brain tumors. Curr Opin Oncol 2002; 14:292-98
4. Majó s C, Alonso J, Aguilera C, et al. Proton magnetic resonance spectroscopy (1H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization. Eur Radiol 2003;13:582-91
5. McKnight TR. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Semin Oncol 2004;31:605-17
6. Möller-Hartmann W, Herminghaus S, Krings T, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44:371-81
7. Murphy M, Loosemore A, Clifton AG, et al. The contribution of proton magnetic resonance spectroscopy (1HMRS)to clinical brain tumour diagnosis. Br J Neurosurg 2002;16:329-34
8. Nelson SJ. Multivoxel magnetic resonance spectroscopy of brain tumors. Mol Cancer Ther 2003;2:497-507
9. Murphy PS, Dzik-Jurasz AS, Leach MO, et al. The effect of Gd-DTPA on T(1)-weighted choline signal in human brain tumours. Magn Reson Imaging 2002;20:127-30
10. Sijens PE, Oudkerk M, van Dijk P, et al. 1HMR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration. Magn Reson Imaging 1998;16:1273-80
11. Sijens PE, van den Bent MJ, Nowak PJ, et al. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 1997;37:222-25
12. Smith JK, Kwock L, Castillo M. Effects of contrast material on single-volume proton MR spectroscopy. AJNR Am J Neuroradiol 2000;21:1084-89
13. Lukas L, Devos A, Suykens JA, et al. Brain tumor classification based on long echo proton MRS signals. Artif Intell Med 2004;31:73-89
14. Maheshwari SR, Fatterpekar GM, Castillo M, et al. Proton MR spectroscopy of the brain. Semin Ultrasound CT MR 2000;21:434-51
15. Meyerand ME, Pipas JM, Mamourian A, et al. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol 1999;20:117-23
16. Fountas KN, Kapsalaki EZ, Vogel RL, et al. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 2004;82:90-97
17. Murphy PS, Leach MO, Rowland IJ. Signal modulation in (1)H magnetic resonance spectroscopy using contrast agents: proton relaxivities of choline, creatine, and N-acetylaspartate. Magn Reson Med 1999;42:1155-58
18. Lin AP, Ross BD. Short-echo time proton MR spectroscopy in the presence of gadolinium. J Comput Assist Tomogr 2001;25:705-12
19. Murphy PS, Leach MO, Rowland IJ. The effects of paramagnetic contrast agents on metabolite protons in aqueous solution. Phys Med Biol 2002;47:N53-59